RT @RichardPAConway: Ferrada @maferradastrong et al. HSCT in VEXAS. 20 evaluated. Indications refractory disease or haem
Tweet Content
Ferrada @maferradastrong et al. HSCT in VEXAS. 20 evaluated. Indications refractory disease or haematologic abnormalities. Completed in 2, ongoing in 2. @RheumNow #ACR22 Abstr#1568 https://t.co/01SeHQcIsh https://t.co/XCgz4cTQCJ
Links
Evaluation for Allogeneic Hematopoietic Stem Cell Transplant Indications and El…
https://acrabstracts.org/abstract/evaluation-for-allogeneic-hematopoietic-stem-…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off